JAGUAR HEALTH, INC. Total Assets
JAGUAR HEALTH, INC. (JAGX) had Total Assets of $34.19 million as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-08-19
- 2026-06-30: Assets $34.19M.
- 2026-03-31: Assets $37.43M.
- 2025-12-31: Assets $38.32M.
- 2025-09-30: Assets $49.47M.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2026-06-30 | $34.19M 10-Q · filed 2026-08-19 | |
| 2026-03-31 | $37.43M 10-Q · filed 2026-05-20 | |
| 2025-12-31 | $38.32M 10-Q · filed 2026-08-19 | |
| 2025-09-30 | $49.47M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $48.27M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $51.46M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $53.42M 10-K · filed 2026-04-07 | |
| 2024-09-30 | $58.47M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $61.46M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $55.39M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $50.76M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $45.38M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $52.17M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $56.93M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $47.45M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $51.29M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $49.88M 10-Q · filed 2022-08-22 | |
| 2022-03-31 | $52.91M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $53.27M 10-K · filed 2023-03-24 | |
| 2021-09-30 | $59.26M 10-Q · filed 2021-11-17 | |
| 2021-06-30 | $69.54M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $68.71M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $42.84M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $36.23M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $37.58M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $33.28M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $36.41M 10-K · filed 2021-03-31 | $36.41M 10-K · filed 2020-04-03 |
| 2019-09-30 | $35.63M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $36.07M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $40.66M 10-Q · filed 2019-05-21 | |
| 2018-12-31 | $41.04M 10-K · filed 2020-04-03 | |
| 2018-09-30 | $46.12M 10-Q · filed 2018-11-19 | |
| 2018-06-30 | $46.16M 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $50.27M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $43.63M 10-K · filed 2019-04-10 | |
| 2017-09-30 | $59.99M 10-Q · filed 2017-11-20 | |
| 2017-06-30 | $4.94M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $3.57M 10-Q/A · filed 2017-06-23 | |
| 2016-12-31 | $3.56M 10-K · filed 2018-04-09 | |
| 2016-09-30 | $5.10M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $7.20M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $11.98M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $12.41M 10-K · filed 2017-02-15 | |
| 2015-09-30 | $16.64M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $13.86M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $4.84M 10-Q · filed 2015-06-26 | |
| 2014-12-31 | $4.42M 10-K · filed 2016-03-29 | $4.51M 10-Q · filed 2015-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |